CAMBRIDGE, Mass. & MUNICH, Germany--(BUSINESS WIRE)--Archemix Corp. and NascaCell Technologies AG announced today an expansion of their strategic alliance focused on the use and development of aptamers for drug discovery applications.
CAMBRIDGE, Mass. & MUNICH, Germany--(BUSINESS WIRE)--Archemix Corp. and NascaCell Technologies AG announced today an expansion of their strategic alliance focused on the use and development of aptamers for drug discovery applications.
